To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SNRPATABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
304 representative clones for gene SNRPA back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA617912   .a 1 to 537 2 to 542   tiling clone, capped   541/541
(100 %)
2 diff
(99.7 %id)
BG396602 eye, retinoblastoma .a 18 to 544 1 to 530       530/530
(100 %)
16 diff
(97.0 %id)
AA010983 heart .a 67 to 553 1 to 485   tiling clone,   487/486
(100 %)
6 diff
(98.8 %id)
AA010651 heart .a 960 to 1155 200 to 1   tiling clone,   200/200
(100 %)
5 diff
(97.5 %id)
DB053714 testis .b 1 to 571 2 to 572   tiling clone, capped   571/571
(100 %)
1 diff
(99.9 %id)
DA001385   .b 152 to 652 2 to 503   capped   502/502
(100 %)
2 diff
(99.7 %id)
CN286572 embryonic stem cells, cell lines H1, H7, andH9 .b 160 to 892 1 to 733       733/733
(100 %)
2 diff
(99.8 %id)
NM_004596.4   .b 162 to 1789 1 to 1628 exact RefSeq, AAA   1628/1628
(100 %)
0 diff
(100 %id)
BQ226242 melanotic melanoma, skin .b 164 to 947 1 to 799       799/903
(88 %)
33 diff
(96.4 %id)
CN286561 embryonic stem cells, DMSO-treated H9 cellline .b 167 to 923 1 to 757       757/757
(100 %)
1 diff
(99.9 %id)
CR597793 neuroblastoma .b 172 to 1761 1 to 1590 exact     1590/1590
(100 %)
0 diff
(100 %id)
CR606390 Neuroblastoma Cot 50-normalized .b 172 to 1768 1 to 1597 exact     1597/1597
(100 %)
0 diff
(100 %id)
AL530234 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .b 172 to 891 1 to 719   fully sequenced,   719/719
(100 %)
5 diff
(99.4 %id)
DC387034   .b 173 to 731 1 to 559       559/559
(100 %)
0 diff
(100 %id)
CD049641 embryonic stem cells, WA01, passage 38 .b 174 to 1041 26 to 893       868/898
(96 %)
10 diff
(98.9 %id)
BI770022 pooled lung and spleen .b 175 to 1061 1 to 888       888/900
(98 %)
19 diff
(97.9 %id)
BM466034 embryonal carcinoma, cell line, testis .b 176 to 907 1 to 732       732/1056
(69 %)
15 diff
(98.6 %id)
BC000405 Lung, small cell carcinoma .b 182 to 1785 1 to 1604 exact available from MGC, AAA   1604/1604
(100 %)
1 diff
(100.0 %id)
TI_57241380   .b 187 to 1070 34 to 921       888/921
(96 %)
21 diff
(97.8 %id)
BI913622 brain .b 188 to 1070 1 to 887       887/887
(100 %)
18 diff
(98.0 %id)
CR597355 fetal liver .b 190 to 1754 1 to 1565 exact     1565/1565
(100 %)
0 diff
(100 %id)
CR602490 Neuroblastoma Cot 25-normalized .b 190 to 1756 1 to 1567 exact     1567/1567
(100 %)
0 diff
(100 %id)
CR607723 HeLa cells Cot 25-normalized .b 190 to 1708 1 to 1519 exact     1519/1519
(100 %)
0 diff
(100 %id)
AL525704 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 190 to 993 1 to 802   fully sequenced,   802/802
(100 %)
3 diff
(99.7 %id)
BX383865   .b 190 to 1020 1 to 829   fully sequenced,   829/829
(100 %)
4 diff
(99.6 %id)
BX422424 fetal liver, Liver .b 190 to 1023 1 to 833   fully sequenced,   833/833
(100 %)
5 diff
(99.4 %id)
BQ059771 lymph, lymphoma, cell line .b 190 to 1018 1 to 844       844/1028
(82 %)
23 diff
(97.8 %id)
BM562047 leukocyte .b 193 to 1122 15 to 946       932/1090
(85 %)
28 diff
(97.5 %id)
CR611065 T cells (Jurkat cell line) Cot10-normalized .b 194 to 1716 1 to 1523 exact     1523/1523
(100 %)
0 diff
(100 %id)
CR620163 Neuroblastoma Cot 10-normalized .b 194 to 1753 1 to 1560 exact     1560/1560
(100 %)
0 diff
(100 %id)
BX325024   .b 194 to 957 1 to 767   fully sequenced,   767/767
(100 %)
6 diff
(99.3 %id)
BI768440 pooled lung and spleen .b 194 to 1143 1 to 947       947/969
(97 %)
19 diff
(98.1 %id)
TI_57178606   .b 194 to 1143 61 to 1007       947/1029
(92 %)
25 diff
(97.6 %id)
TI_57175901   .b 195 to 1030 63 to 896       834/975
(85 %)
19 diff
(98.1 %id)
TI_57239895   .b 195 to 929 65 to 799       735/799
(91 %)
6 diff
(99.3 %id)
BI829168 brain, medulla .b 196 to 1030 1 to 833       833/912
(91 %)
15 diff
(98.4 %id)
BI916363 brain .b 196 to 929 1 to 734       734/734
(100 %)
2 diff
(99.8 %id)
BQ430334 embryonal carcinoma, cell line, testis .b 197 to 1071 1 to 881       881/881
(100 %)
15 diff
(98.3 %id)
BF971563 leiomyosarcoma cell line, uterus .b 199 to 1075 1 to 885       885/901
(98 %)
32 diff
(96.5 %id)
BI837156 pooled pancreas and spleen .b 199 to 1085 1 to 883       883/953
(92 %)
19 diff
(98.1 %id)
BG824769 adenocarcinoma cell line, colon .b 201 to 1015 1 to 814       814/816
(99 %)
6 diff
(99.3 %id)
BM920787 pooled brain, lung, testis .b 201 to 1121 1 to 936       934/1051
(88 %)
35 diff
(96.7 %id)
BQ689851 ductal carcinoma, cell line, Pancreas .b 201 to 1042 1 to 850       850/879
(96 %)
9 diff
(99.0 %id)
BQ686239 ductal carcinoma, cell line, Pancreas .b 201 to 1071 1 to 872       872/872
(100 %)
8 diff
(99.1 %id)
BQ689050 ductal carcinoma, cell line, Pancreas .b 201 to 962 1 to 763       763/901
(84 %)
12 diff
(98.7 %id)
BQ691097 ductal carcinoma, cell line, Pancreas .b 201 to 963 1 to 771       771/948
(81 %)
13 diff
(98.7 %id)
CV808908 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 201 to 968 1 to 770       770/889
(86 %)
15 diff
(98.4 %id)
TI_57167835   .b 201 to 1085 38 to 918       881/988
(89 %)
20 diff
(98.0 %id)
BQ930876 epidermoid carcinoma, cell line, lung .b 202 to 1122 1 to 924       924/960
(96 %)
24 diff
(97.5 %id)
TI_43960769   .b 206 to 1071 56 to 918       863/918
(94 %)
8 diff
(99.2 %id)
BI489989 pooled brain, lung, testis .b 207 to 1071 1 to 862       862/862
(100 %)
4 diff
(99.6 %id)
BI764236 pooled colon, kidney, stomach .b 208 to 1015 1 to 806       806/807
(99 %)
6 diff
(99.3 %id)
CN286573 embryonic stem cells, cell lines H1, H7, andH9 .b 210 to 923 1 to 714       714/714
(100 %)
1 diff
(99.9 %id)
TI_57234638   .b 215 to 985 26 to 794       769/794
(96 %)
6 diff
(99.3 %id)
BQ064240 lymph, lymphoma, cell line .b 218 to 1122 1 to 910       910/1005
(90 %)
17 diff
(98.4 %id)
BI908716 leukocyte .b 223 to 985 1 to 762       762/762
(100 %)
1 diff
(99.9 %id)
BQ109525 leukocyte .b 223 to 928 1 to 706       706/707
(99 %)
5 diff
(99.3 %id)
BM803918 leiomyosarcoma, uterus .b 228 to 1112 1 to 887       887/1030
(86 %)
14 diff
(98.7 %id)
BM800862 melanotic melanoma, skin .b 228 to 963 1 to 740       740/1096
(67 %)
18 diff
(98.4 %id)
BE616725 adenocarcinoma, Pancreas .b 235 to 1058 58 to 882       825/1004
(82 %)
22 diff
(97.9 %id)
BM923215 pooled colon, kidney, stomach .b 239 to 1122 19 to 902       884/1113
(79 %)
24 diff
(97.9 %id)
TI_57174813   .b 239 to 962 33 to 757       725/866
(83 %)
15 diff
(98.3 %id)
BI827275 brain, medulla .b 240 to 962 1 to 724       724/833
(86 %)
10 diff
(98.8 %id)
BE616063 adenocarcinoma, Pancreas .b 247 to 1143 1 to 901       901/934
(96 %)
39 diff
(95.9 %id)
BE531105 adenocarcinoma, Pancreas .b 248 to 1009 1 to 753       753/787
(95 %)
16 diff
(98.0 %id)
CR614230 placenta .b 252 to 1781 1 to 1530 exact tiling clone,   1530/1530
(100 %)
0 diff
(100 %id)
BX417759 placenta .b 252 to 1280 1 to 1013       1013/1013
(100 %)
20 diff
(98.1 %id)
BM548236 brain, hippocampus .b 267 to 1127 20 to 887       868/1051
(82 %)
22 diff
(98.0 %id)
TI_154185918   .b 336 to 1151 113 to 915       803/940
(85 %)
42 diff
(95.6 %id)
BI550139 brain, hippocampus .b 445 to 1215 1 to 770       770/770
(100 %)
9 diff
(98.9 %id)
TI_44169981   .b 448 to 1215 133 to 899       767/899
(85 %)
18 diff
(98.0 %id)
CR612581 fetal brain .b 475 to 1780 1 to 1306 exact     1306/1306
(100 %)
0 diff
(100 %id)
DA116942 cerebellum .b 503 to 1035 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
BI597696 brain, hypothalamus .b 506 to 1305 1 to 803       803/804
(99 %)
19 diff
(97.7 %id)
BP357809 mammary gland .b 507 to 1078 1 to 573       573/583
(98 %)
2 diff
(99.7 %id)
BG257028 embryonal carcinoma, cell line, testis .b 511 to 1310 1 to 791       791/985
(80 %)
35 diff
(96.5 %id)
CR604415 Placenta Cot 25-normalized .b 512 to 1772 1 to 1261 exact     1261/1261
(100 %)
0 diff
(100 %id)
CR617901 Neuroblastoma Cot 25-normalized .b 512 to 1761 1 to 1250 exact     1250/1250
(100 %)
0 diff
(100 %id)
AL524660 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 512 to 1173 1 to 660   fully sequenced,   660/660
(100 %)
6 diff
(99.1 %id)
BX335505 Placenta Cot 25-normalized .b 512 to 1173 1 to 661   fully sequenced,   661/661
(100 %)
5 diff
(99.3 %id)
DR759549 embryonic stem .b 513 to 1121 1 to 609       609/609
(100 %)
1 diff
(99.9 %id)
BI091580 cervix .b 516 to 1151 1 to 637       637/752
(84 %)
20 diff
(97.4 %id)
BM555092 duodenal adenocarcinoma, cell line, small intestine .b 516 to 1316 1 to 813       813/1115
(72 %)
21 diff
(98.2 %id)
BQ060092 lymph, lymphoma, cell line .b 516 to 1122 20 to 625       606/629
(96 %)
7 diff
(98.9 %id)
BU149133 sympathetic trunk .b 516 to 1129 6 to 622       617/920
(67 %)
16 diff
(98.3 %id)
TI_154171102   .b 516 to 1315 91 to 882       792/1228
(64 %)
29 diff
(97.7 %id)
CR614107 Neuroblastoma Cot 50-normalized .b 520 to 1776 1 to 1257 exact     1257/1257
(100 %)
0 diff
(100 %id)
BX376614 Neuroblastoma Cot 50-normalized .b 520 to 1199 1 to 677   fully sequenced,   677/677
(100 %)
4 diff
(99.5 %id)
BG913339 anaplastic oligodendroglioma with 1p/19qloss, brain .b 520 to 1405 1 to 884       884/929
(95 %)
33 diff
(96.5 %id)
BI488528 brain .b 520 to 1354 1 to 833       833/836
(99 %)
14 diff
(98.4 %id)
BI521163 pooled pancreas and spleen .b 520 to 1229 1 to 708       708/708
(100 %)
8 diff
(98.9 %id)
TI_45379049   .b 520 to 1354 74 to 906       835/909
(91 %)
21 diff
(97.7 %id)
TI_57231783   .b 520 to 1305 33 to 819       787/819
(96 %)
15 diff
(98.2 %id)
TI_154194159   .b 521 to 1316 50 to 839       790/1000
(79 %)
7 diff
(99.3 %id)
BF980515 duodenal adenocarcinoma, cell line, small intestine .b 522 to 1141 1 to 617       617/901
(68 %)
7 diff
(99.3 %id)
CF128304 Chondrosarcoma Lung Metastasis cell lines, lung .b 522 to 1316 1 to 789       789/814
(96 %)
7 diff
(99.2 %id)
TI_57234196   .b 522 to 1229 62 to 769       708/769
(92 %)
10 diff
(98.7 %id)
CR595370 Neuroblastoma Cot 25-normalized .b 524 to 1774 1 to 1251 exact     1251/1251
(100 %)
0 diff
(100 %id)
BX376255 Neuroblastoma Cot 25-normalized .b 524 to 1173 1 to 647   fully sequenced,   647/647
(100 %)
1 diff
(99.9 %id)
BI909582 leukocyte .b 524 to 1143 1 to 619       619/775
(79 %)
17 diff
(97.9 %id)
TI_57237855   .b 524 to 1143 29 to 647       619/803
(77 %)
17 diff
(97.9 %id)
BI017847 lung_tumor .b 525 to 943 1 to 422       422/433
(97 %)
23 diff
(94.7 %id)
CR613649 T cells (Jurkat cell line) Cot10-normalized .b 525 to 1723 1 to 1199 exact     1199/1199
(100 %)
0 diff
(100 %id)
BI836822 pooled pancreas and spleen .b 525 to 1354 1 to 822       824/823
(100 %)
25 diff
(97.0 %id)
TI_57164171   .b 525 to 1354 73 to 894       823/895
(91 %)
30 diff
(96.7 %id)
CR591403 Neuroblastoma Cot 10-normalized .b 526 to 1772 1 to 1247 exact     1247/1247
(100 %)
0 diff
(100 %id)
CR593045 Neuroblastoma Cot 50-normalized .b 526 to 1769 1 to 1244 exact     1244/1244
(100 %)
0 diff
(100 %id)
AL520654 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .b 526 to 1173 1 to 646   fully sequenced,   646/646
(100 %)
1 diff
(99.9 %id)
BQ227253 embryonal carcinoma, cell line, testis .b 526 to 1141 1 to 616       616/907
(67 %)
6 diff
(99.4 %id)
BI905814 leukocyte .b 528 to 1305 1 to 779       779/779
(100 %)
11 diff
(98.6 %id)
BI907674 leukocyte .b 528 to 1229 1 to 702       702/702
(100 %)
4 diff
(99.5 %id)
CN286578 embryonic stem cells, cell lines H1, H7, andH9 .b 532 to 1120 1 to 589       589/589
(100 %)
3 diff
(99.5 %id)
CR597345 Neuroblastoma Cot 25-normalized .b 533 to 1756 1 to 1224 exact     1224/1224
(100 %)
0 diff
(100 %id)
BX354238 Neuroblastoma Cot 25-normalized .b 533 to 1173 1 to 636   fully sequenced,   636/636
(100 %)
1 diff
(99.9 %id)
BI258603 cervical carcinoma cell line, cervix .b 534 to 1310 1 to 779       779/780
(99 %)
11 diff
(98.6 %id)
BU191623 eye, retinoblastoma .b 534 to 1123 12 to 602       591/606
(97 %)
8 diff
(98.7 %id)
BM452645 lymph, lymphoma, cell line .b 535 to 1129 1 to 596       596/1089
(54 %)
8 diff
(99.3 %id)
BM806788 melanotic melanoma, skin .b 536 to 1414 1 to 884       882/1014
(86 %)
30 diff
(97.1 %id)
TI_59382155   .b 536 to 1316 97 to 876       780/898
(86 %)
25 diff
(97.3 %id)
BM012923 brain, neuroblastoma, cell line .b 537 to 1316 1 to 779       779/897
(86 %)
25 diff
(97.3 %id)
BI760880 pooled colon, kidney, stomach .b 538 to 1171 1 to 631       631/631
(100 %)
5 diff
(99.3 %id)
CX786666 human embryonic stem cells .b 538 to 1362 1 to 825       825/825
(100 %)
1 diff
(99.9 %id)
TI_57146932   .b 538 to 1171 30 to 660       631/660
(95 %)
6 diff
(99.1 %id)
AL042711 testis .b 539 to 1143 11 to 628       618/791
(78 %)
21 diff
(97.4 %id)
BE732747 choriocarcinoma, placenta .b 540 to 1230 1 to 685       685/687
(99 %)
11 diff
(98.4 %id)
BE732526 choriocarcinoma, placenta .b 540 to 1131 1 to 591       591/591
(100 %)
1 diff
(99.9 %id)
BE889079 leiomyosarcoma, uterus .b 542 to 1178 1 to 638       638/638
(100 %)
8 diff
(98.8 %id)
BG477784 melanotic melanoma, skin .b 543 to 1372 1 to 816       819/883
(92 %)
32 diff
(96.4 %id)
BG478688 melanotic melanoma, skin .b 543 to 1314 1 to 771       773/800
(96 %)
30 diff
(96.3 %id)
BM917739 blood, natural killer cells, cell line .b 544 to 1122 1 to 578       578/1085
(53 %)
6 diff
(99.5 %id)
CN286569 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 545 to 1107 1 to 562       562/567
(99 %)
2 diff
(99.7 %id)
CA489577   .b 545 to 1122 1 to 576       576/871
(66 %)
7 diff
(99.2 %id)
BX425184 neuroblastoma .b 548 to 1172 1 to 627   fully sequenced,   629/629
(100 %)
8 diff
(98.8 %id)
CR620634 neuroblastoma .b 548 to 1775 1 to 1228 exact     1228/1228
(100 %)
0 diff
(100 %id)
AK313182   .b 549 to 1565 1 to 1017 K88R     1017/1017
(100 %)
2 diff
(99.9 %id)
BE778134 eye, retinoblastoma .b 549 to 1193 1 to 635       635/883
(71 %)
12 diff
(98.7 %id)
DA617323   .b 550 to 1119 2 to 571   capped   570/570
(100 %)
3 diff
(99.5 %id)
BE787635 large cell carcinoma, lung .b 554 to 1286 1 to 723       723/781
(92 %)
21 diff
(97.4 %id)
BE622472 melanotic melanoma, skin .b 556 to 1193 1 to 627       627/760
(82 %)
13 diff
(98.3 %id)
BQ212231 melanotic melanoma, skin .b 560 to 1141 11 to 597       587/1002
(58 %)
15 diff
(98.6 %id)
CB993368 placenta, pre-eclamptic placenta .b 560 to 1122 28 to 599       572/851
(67 %)
25 diff
(97.1 %id)
CB130704 Liver .b 563 to 1081 1 to 519       519/519
(100 %)
4 diff
(99.3 %id)
BF026772 melanotic melanoma, skin .b 564 to 1239 1 to 670       670/696
(96 %)
20 diff
(97.2 %id)
AA311059   .b 571 to 1058 1 to 491       491/491
(100 %)
5 diff
(99.0 %id)
BE548036 cervical carcinoma cell line, cervix .b 572 to 1198 1 to 622       622/807
(77 %)
11 diff
(98.7 %id)
AU100381   .b 578 to 877 1 to 300       300/300
(100 %)
5 diff
(98.4 %id)
BE408068 choriocarcinoma, placenta .b 579 to 1385 1 to 802       802/874
(91 %)
18 diff
(98.0 %id)
CN286562 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 580 to 1112 1 to 533       533/533
(100 %)
2 diff
(99.7 %id)
BE734772 choriocarcinoma, placenta .b 581 to 1469 29 to 903       875/969
(90 %)
33 diff
(96.6 %id)
BF305411 muscle, rhabdomyosarcoma .b 581 to 1176 1 to 603       583/604
(96 %)
29 diff
(95.2 %id)
BG827174 muscle, rhabdomyosarcoma .b 581 to 1276 1 to 693       693/693
(100 %)
21 diff
(97.0 %id)
BE734932 choriocarcinoma, placenta .b 582 to 1470 32 to 921       890/1188
(74 %)
30 diff
(97.5 %id)
CX166667 human embryonic stem cells differentiated toan early endodermal cell type .b 583 to 1355 1 to 773       773/773
(100 %)
0 diff
(100 %id)
BP220118 colon .b 585 to 1152 1 to 567       567/567
(100 %)
16 diff
(97.2 %id)
DT219718 brain .b 585 to 1112 1 to 528       528/528
(100 %)
1 diff
(99.9 %id)
BG576032 breast, mammary adenocarcinoma, cell line .b 586 to 1330 1 to 748       748/748
(100 %)
8 diff
(99.0 %id)
CN286570 embryonic stem cells, cell lines H1, H7, andH9 .b 587 to 1122 1 to 534       534/538
(99 %)
9 diff
(98.4 %id)
X06347 teratocarcinoma. .b 592 to 1787 1 to 1196 exact     1196/1209
(98 %)
5 diff
(99.6 %id)
CN286579 embryonic stem cells, cell lines H1, H7, andH9 .b 593 to 1105 1 to 513       513/513
(100 %)
4 diff
(99.3 %id)
CN286574 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 594 to 1278 1 to 686       686/686
(100 %)
8 diff
(98.9 %id)
CN286568 embryonic stem cells, cell lines H1, H7, andH9 .b 596 to 1112 1 to 517       517/517
(100 %)
3 diff
(99.5 %id)
BM923824 pooled colon, kidney, stomach .b 596 to 1140 1 to 540       540/1098
(49 %)
12 diff
(99.0 %id)
BM051616 Burkitt lymphoma, lymph .b 597 to 1374 1 to 776       776/776
(100 %)
18 diff
(97.7 %id)
CX784853 human embryonic stem cells .b 597 to 1455 1 to 857       857/857
(100 %)
4 diff
(99.6 %id)
BC008290 Lymph, Burkitt lymphoma .b 598 to 1785 1 to 1188 exact available from MGC, AAA   1188/1188
(100 %)
0 diff
(100 %id)
BE732963 choriocarcinoma, placenta .b 599 to 1304 1 to 687       687/687
(100 %)
19 diff
(97.3 %id)
BQ923703 eye, normal pigmented retinal epithelium .b 600 to 1414 1 to 819       819/950
(86 %)
23 diff
(97.6 %id)
CB960452 Human Placenta, placenta .b 600 to 1149 28 to 578       551/848
(64 %)
16 diff
(98.2 %id)
BE261191 brain, neuroblastoma .b 601 to 1230 1 to 622       622/676
(92 %)
8 diff
(98.9 %id)
BG479185 choriocarcinoma, placenta .b 601 to 1414 1 to 818       818/818
(100 %)
23 diff
(97.2 %id)
BG468870 adenocarcinoma cell line, colon .b 604 to 1226 1 to 628       628/836
(75 %)
15 diff
(98.3 %id)
BI017859 lung_tumor .b 606 to 948 52 to 392       341/392
(86 %)
7 diff
(98.3 %id)
CB129486 Liver .b 606 to 1027 1 to 422       422/422
(100 %)
1 diff
(99.8 %id)
CB145609 Liver .b 606 to 1074 1 to 469       469/469
(100 %)
2 diff
(99.6 %id)
BG105763 adrenal cortex carcinoma, cell line, adrenal gland .b 612 to 1280 1 to 659       659/766
(86 %)
12 diff
(98.5 %id)
CN286577 embryonic stem cells, cell lines H1, H7, andH9 .b 615 to 1115 20 to 520       501/520
(96 %)
6 diff
(98.9 %id)
CR611939 T cells (Jurkat cell line) Cot10-normalized .b 615 to 1731 1 to 1117 exact     1117/1117
(100 %)
0 diff
(100 %id)
AL559056 T cells from T cell leukemia .b 615 to 1353 1 to 738       738/738
(100 %)
2 diff
(99.8 %id)
BX402880   .b 615 to 1633 1 to 1009 P187R Q188S Q189S M191C P192Q ...     1009/1009
(100 %)
11 diff
(99.0 %id)
BE267649 Burkitt lymphoma, lymph .b 617 to 1255 1 to 637       637/637
(100 %)
5 diff
(99.3 %id)
BE269541 Burkitt lymphoma, lymph .b 617 to 1183 1 to 567       567/567
(100 %)
1 diff
(99.9 %id)
BE561196 Burkitt lymphoma, lymph .b 617 to 1372 1 to 744       744/746
(99 %)
17 diff
(97.8 %id)
BE559991 Burkitt lymphoma, lymph .b 617 to 1414 1 to 790       790/1071
(73 %)
28 diff
(97.4 %id)
BE559672 Burkitt lymphoma, lymph .b 617 to 1299 1 to 675       675/675
(100 %)
16 diff
(97.7 %id)
BG328370 adenocarcinoma cell line, colon .b 618 to 1405 1 to 782       782/894
(87 %)
26 diff
(97.1 %id)
BG574857 breast, mammary adenocarcinoma, cell line .b 618 to 1405 1 to 796       796/803
(99 %)
15 diff
(98.2 %id)
CR609533 Neuroblastoma Cot 25-normalized .b 619 to 1770 1 to 1152 exact     1152/1152
(100 %)
0 diff
(100 %id)
CR622302 Neuroblastoma Cot 25-normalized .b 619 to 1783 1 to 1165 exact     1165/1165
(100 %)
0 diff
(100 %id)
AL523990 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 619 to 1376 1 to 757   fully sequenced,   757/757
(100 %)
3 diff
(99.7 %id)
BX332315 Neuroblastoma Cot 25-normalized .b 619 to 1072 1 to 454       454/454
(100 %)
47 diff
(89.7 %id)
BX402083 Neuroblastoma Cot 25-normalized .b 619 to 1667 1 to 1041 P197L A198P Q199S P200L L201F ...     1041/1041
(100 %)
15 diff
(98.6 %id)
DR759558 embryonic stem .b 619 to 1160 10 to 551       542/551
(98 %)
5 diff
(99.1 %id)
BX427443 fetal liver, Liver .b 620 to 1650 1 to 1024 P196X P206X E254X G266A K268X ...     1024/1024
(100 %)
21 diff
(98.0 %id)
CN286559 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 622 to 1245 9 to 634       626/634
(98 %)
2 diff
(99.7 %id)
BM888489 eye .b 623 to 1182 1 to 564       561/582
(96 %)
3 diff
(99.5 %id)
BG287051 bladder, transitional cell papilloma, cell line .b 623 to 1228 1 to 608   AAA   608/1083
(56 %)
9 diff
(99.2 %id)
BU180799 large cell carcinoma, lung .b 623 to 1122 1 to 501       501/976
(51 %)
6 diff
(99.4 %id)
CF126649 Chondrosarcoma Lung Metastasis cell lines, lung .b 628 to 1394 1 to 765       765/765
(100 %)
7 diff
(99.1 %id)
TI_154189668   .b 628 to 1516 48 to 926       879/1010
(87 %)
18 diff
(98.3 %id)
AI928950 brain, frontal lobe .b 630 to 1143 1 to 512       512/512
(100 %)
4 diff
(99.3 %id)
AW160891 brain, frontal lobe .b 630 to 1099 1 to 470       470/470
(100 %)
1 diff
(99.8 %id)
BU949457 Pancreas, Purified pancreatic islet .b 630 to 1112 1 to 483       483/483
(100 %)
0 diff
(100 %id)
AA359464 lung .b 632 to 916 1 to 286       286/286
(100 %)
3 diff
(99.0 %id)
BP871078 embryonal kidney .b 636 to 967 332 to 1     Submitted on the opposite strand 332/332
(100 %)
0 diff
(100 %id)
AA295764 Pancreas .b 640 to 940 1 to 301       301/303
(99 %)
2 diff
(99.4 %id)
R75909 breast .b 640 to 962 16 to 341       326/463
(70 %)
12 diff
(97.5 %id)
BE788219 large cell carcinoma, lung .b 644 to 1204 1 to 554       554/875
(63 %)
14 diff
(98.4 %id)
CN286566 embryonic stem cells, DMSO-treated H9 cellline .b 646 to 1177 1 to 534       534/534
(100 %)
2 diff
(99.7 %id)
CN286576 embryonic stem cells, DMSO-treated H9 cellline .b 647 to 1110 9 to 473       465/473
(98 %)
1 diff
(99.8 %id)
AA448458   .b 654 to 1213 12 to 565       556/571
(97 %)
20 diff
(96.5 %id)
BG035894 adenocarcinoma, cell line, Liver .b 657 to 1404 1 to 745       745/1074
(69 %)
14 diff
(98.7 %id)
BM801383 duodenal adenocarcinoma, cell line, small intestine .b 673 to 1123 35 to 484       450/1128
(39 %)
10 diff
(99.2 %id)
BE019956 adenocarcinoma cell line, ovary .b 674 to 1347 1 to 675   fully sequenced,   675/675
(100 %)
11 diff
(98.4 %id)
DN995364 breast cancer, Mammary gland (cancer tissue) .b 693 to 1046 6 to 358       353/358
(98 %)
6 diff
(98.4 %id)
BG577318 breast, mammary adenocarcinoma, cell line .b 695 to 1392 1 to 699       699/699
(100 %)
1 diff
(99.9 %id)
BM855429 Ascites, stomach .b 696 to 1114 1 to 418       418/418
(100 %)
3 diff
(99.3 %id)
BG719150 testis .b 714 to 1122 241 to 651       411/651
(63 %)
10 diff
(98.5 %id)
BG335811 choriocarcinoma, placenta .b 726 to 1296 1 to 575       575/1045
(55 %)
29 diff
(97.3 %id)
CR977114 T-Lymphocytes .b 731 to 1231 1 to 503       503/504
(99 %)
4 diff
(99.3 %id)
BE733579 choriocarcinoma, placenta .b 747 to 1498 1 to 759       759/942
(80 %)
16 diff
(98.4 %id)
BM459069 melanotic melanoma, skin .b 759 to 1124 1 to 365       365/1121
(32 %)
5 diff
(99.6 %id)
N55234 multiple sclerosis lesions .b 784 to 956 1 to 172       172/175
(98 %)
7 diff
(96.0 %id)
CN286560 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 787 to 1073 1 to 287       287/287
(100 %)
4 diff
(98.7 %id)
BG165497 hypernephroma, cell line, Kidney .b 791 to 1262 1 to 473       473/1026
(46 %)
12 diff
(98.9 %id)
CR624653 Neuroblastoma Cot 50-normalized .b 793 to 1787 1 to 995       995/995
(100 %)
0 diff
(100 %id)
BQ917325 large cell carcinoma, lung .b 811 to 1740 1 to 945       945/950
(99 %)
36 diff
(96.3 %id)
BE879259 large cell carcinoma, undifferentiated, lung .b 817 to 1556 1 to 730       730/730
(100 %)
21 diff
(97.2 %id)
BX402082 Neuroblastoma Cot 25-normalized .b 826 to 1775 943 to 1       943/947
(99 %)
11 diff
(98.9 %id)
AL563678 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .b 861 to 1768 910 to 1   fully sequenced,   910/910
(100 %)
20 diff
(97.9 %id)
BF305994 muscle, rhabdomyosarcoma .b 899 to 1649 1 to 737       737/868
(84 %)
30 diff
(96.6 %id)
BX325023   .b 927 to 1716 800 to 1   fully sequenced,   800/800
(100 %)
19 diff
(97.7 %id)
BM852353 Ascites, stomach .b 943 to 1120 1 to 178       178/178
(100 %)
6 diff
(96.7 %id)
AL562585 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 962 to 1727 803 to 30   fully sequenced,   774/803
(96 %)
3 diff
(99.7 %id)
BG251378 adenocarcinoma, cell line, Liver .b 962 to 1731 22 to 793       772/967
(79 %)
43 diff
(95.6 %id)
BQ645278 hepatocellular carcinoma, cell line, Liver .b 964 to 1785 868 to 40   AAA Submitted on the opposite strand 829/973
(85 %)
20 diff
(98.0 %id)
BI261560 lymph, lymphoma, cell line .b 968 to 1347 1 to 379   fully sequenced,   379/379
(100 %)
3 diff
(99.3 %id)
BM740167 stomach .b 968 to 1112 1 to 145       145/145
(100 %)
0 diff
(100 %id)
BF811152 colon_ins .b 969 to 1226 1 to 258       258/258
(100 %)
1 diff
(99.7 %id)
CN286581 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 971 to 1251 1 to 281       281/281
(100 %)
0 diff
(100 %id)
AL580757 T cells from T cell leukemia .b 979 to 1731 752 to 1       752/752
(100 %)
2 diff
(99.8 %id)
CN286565 embryonic stem cells, DMSO-treated H9 cellline .b 985 to 1267 1 to 283       283/283
(100 %)
2 diff
(99.3 %id)
BQ943561 carcinoma, cell line, Prostate .b 989 to 1785 849 to 45   AAA Submitted on the opposite strand 805/855
(94 %)
11 diff
(98.8 %id)
BX383864   .b 990 to 1708 718 to 1   fully sequenced,   718/718
(100 %)
10 diff
(98.7 %id)
AI125327   .b 992 to 1785 811 to 16   AAA   796/796
(100 %)
12 diff
(98.5 %id)
BX422423 fetal liver, Liver .b 993 to 1754 765 to 1   fully sequenced,   765/765
(100 %)
9 diff
(98.9 %id)
TI_154129676   .b 993 to 1785 884 to 108   AAA   777/954
(81 %)
24 diff
(97.5 %id)
CV806085 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 997 to 1734 1 to 739       739/739
(100 %)
6 diff
(99.2 %id)
BQ943748 carcinoma, cell line, Prostate .b 1012 to 1785 823 to 45   AAA Submitted on the opposite strand 779/937
(83 %)
15 diff
(98.4 %id)
BM701785 eye, optic nerve .b 1027 to 1173 1 to 147   fully sequenced,   147/147
(100 %)
0 diff
(100 %id)
CA418847 Chondrosarcoma Grade II, Left Pelvis .b 1028 to 1785 766 to 19   AAA   748/752
(99 %)
13 diff
(98.3 %id)
BQ650463 hepatocellular carcinoma, cell line, Liver .b 1033 to 1785 814 to 58   AAA Submitted on the opposite strand 757/817
(92 %)
19 diff
(97.7 %id)
BQ447022 Knee, Osteoarthritic Cartilage .b 1036 to 1785 756 to 17   AAA   740/740
(100 %)
11 diff
(98.6 %id)
BU542369 carcinoma, cell line, Prostate .b 1041 to 1785 798 to 45   AAA Submitted on the opposite strand 754/927
(81 %)
12 diff
(98.8 %id)
CA313815 Human Lung Epithelial cells, lung .b 1042 to 1785 759 to 17   AAA   743/743
(100 %)
1 diff
(99.9 %id)
CA306578 Alveolar Macrophage, lung .b 1050 to 1785 754 to 17   AAA   738/738
(100 %)
2 diff
(99.8 %id)
BQ182227 Knee, Osteoarthritic Cartilage .b 1059 to 1783 740 to 19   AAA   722/722
(100 %)
3 diff
(99.6 %id)
BU541141 carcinoma, cell line, Prostate .b 1069 to 1785 768 to 45   AAA Submitted on the opposite strand 724/844
(85 %)
12 diff
(98.6 %id)
BM793971 Ascites, stomach .b 1093 to 1272 1 to 179       179/179
(100 %)
12 diff
(93.3 %id)
CT002425 T-Lymphocytes .b 1104 to 1306 1 to 203       203/203
(100 %)
0 diff
(100 %id)
AL520653 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .b 1112 to 1772 661 to 1   fully sequenced,   661/661
(100 %)
1 diff
(99.9 %id)
AL562374 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 1112 to 1761 649 to 1   fully sequenced,   649/649
(100 %)
13 diff
(98.0 %id)
BX354237 Neuroblastoma Cot 25-normalized .b 1112 to 1756 647 to 1   fully sequenced,   647/647
(100 %)
1 diff
(99.9 %id)
BX376254 Neuroblastoma Cot 25-normalized .b 1112 to 1774 663 to 1   fully sequenced,   663/663
(100 %)
8 diff
(98.8 %id)
BX335504 Placenta Cot 25-normalized .b 1112 to 1767 661 to 5   fully sequenced,   657/661
(99 %)
3 diff
(99.6 %id)
BU633509 cell lines, Chondrosarcoma .b 1112 to 1783 690 to 19   AAA   672/672
(100 %)
0 diff
(100 %id)
CA420448 Bone, Enchondroma cell line .b 1113 to 1785 691 to 19   AAA   673/673
(100 %)
0 diff
(100 %id)
BU728996 eye, optic nerve .b 1114 to 1785 690 to 19   fully sequenced, AAA   672/672
(100 %)
0 diff
(100 %id)
BU630723 cell lines, Chondrosarcoma .b 1123 to 1785 681 to 19   AAA   663/663
(100 %)
0 diff
(100 %id)
BX453967 neuroblastoma .b 1135 to 1775 642 to 1   fully sequenced,   642/642
(100 %)
8 diff
(98.8 %id)
BQ068261 brain .b 1135 to 1783 1 to 649       649/1043
(62 %)
1 diff
(100.0 %id)
BM478204 lymph, lymphoma, cell line .b 1164 to 1772 1 to 609       609/611
(99 %)
1 diff
(99.9 %id)
BX351247 Neuroblastoma Cot 50-normalized .b 1169 to 1776 610 to 1   fully sequenced,   610/610
(100 %)
9 diff
(98.6 %id)
BQ002918 Chondrosarcoma, Left Pelvis .b 1250 to 1789 557 to 19   tiling clone, AAA   539/539
(100 %)
1 diff
(99.9 %id)
DB294971   .b 1259 to 1785 528 to 1       528/528
(100 %)
1 diff
(99.9 %id)
DB545482 hippocampus .b 1268 to 1785 1 to 518     Submitted on the opposite strand 518/518
(100 %)
0 diff
(100 %id)
BE501622 malignant melanoma, metastatic to lymphnode, skin .b 1269 to 1787 519 to 1       519/519
(100 %)
0 diff
(100 %id)
AW848338 colon .b 1271 to 1500 1 to 230       230/230
(100 %)
0 diff
(100 %id)
BE208210 adenocarcinoma cell line, ovary .b 1286 to 1787 504 to 3   fully sequenced,   502/504
(99 %)
0 diff
(100 %id)
BI262176 lymph, lymphoma, cell line .b 1286 to 1731 448 to 1   fully sequenced,   448/448
(100 %)
6 diff
(98.7 %id)
AI929204 brain, frontal lobe .b 1339 to 1787 455 to 7       449/455
(98 %)
0 diff
(100 %id)
AI359889 brain, glioblastoma (pooled) .b 1345 to 1785 441 to 1       441/441
(100 %)
0 diff
(100 %id)
AL523989 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 1346 to 1770 426 to 1   fully sequenced,   426/426
(100 %)
7 diff
(98.4 %id)
BQ671697 epidermoid carcinoma, cell line, salivary gland .b 1362 to 1785 1 to 424   AAA   424/424
(100 %)
0 diff
(100 %id)
AI949381 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 1374 to 1785 412 to 1       412/412
(100 %)
0 diff
(100 %id)
BQ670032 epidermoid carcinoma, cell line, salivary gland .b 1380 to 1785 1 to 406   AAA   406/406
(100 %)
0 diff
(100 %id)
T49870 placenta .b 1449 to 1784 343 to 1       343/410
(83 %)
16 diff
(96.1 %id)
BM718224 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 1489 to 1785 1 to 297   fully sequenced, AAA   297/297
(100 %)
0 diff
(100 %id)
AW168541 bowel (skin primary), metastatic melanoma to bowel .b 1522 to 1785 264 to 1       264/264
(100 %)
0 diff
(100 %id)
BM817994 stomach .b 1621 to 1785 1 to 165   AAA   165/165
(100 %)
0 diff
(100 %id)
BM682690 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 1621 to 1785 181 to 17   fully sequenced, AAA   165/165
(100 %)
0 diff
(100 %id)
AI452558 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 1712 to 1782 71 to 1       71/71
(100 %)
0 diff
(100 %id)
CR606659 Neuroblastoma Cot 25-normalized .c 1 to 1013 1 to 1013 exact tiling clone,   1013/1013
(100 %)
0 diff
(100 %id)
BU601753 mixed (pool of 40 RNAs) .d 1 to 565 1 to 567   tiling clone,   567/843
(67 %)
11 diff
(98.7 %id)
CX788081 human embryonic stem cells .d 19 to 700 1 to 682   tiling clone,   682/682
(100 %)
1 diff
(99.9 %id)
W32737 heart .d 73 to 342 1 to 270       270/270
(100 %)
3 diff
(98.9 %id)
BG683072 brain, neuroblastoma, cell line .d 88 to 597 1 to 508   fully sequenced,   508/508
(100 %)
1 diff
(99.9 %id)
BE731039 choriocarcinoma, placenta .d 107 to 972 1 to 856       856/862
(99 %)
25 diff
(97.1 %id)
BG683722 brain, neuroblastoma, cell line .d 536 to 1157 625 to 1   tiling clone, fully sequenced,   625/625
(100 %)
14 diff
(97.8 %id)
W20492 heart .d 933 to 1209 282 to 1   tiling clone,   282/290
(97 %)
13 diff
(95.6 %id)
AW245839 lung, small cell carcinoma .e 1 to 617 1 to 617   tiling clone,   617/621
(99 %)
6 diff
(99.1 %id)
BX354251 Neuroblastoma Cot 25-normalized .e 11 to 936 1 to 927   tiling clone,   927/1045
(88 %)
6 diff
(99.5 %id)
BX351054 Neuroblastoma Cot 25-normalized .e 957 to 1569 613 to 1   tiling clone,   613/839
(73 %)
7 diff
(99.2 %id)
AW245480 lung, small cell carcinoma .e 1044 to 1578 545 to 11   tiling clone, AAA   535/535
(100 %)
0 diff
(100 %id)
BE797463 lung, small cell carcinoma .f 1 to 695 1 to 694 D2N F34L G35A Q36R I37S ... tiling clone,   694/694
(100 %)
3 diff
(99.6 %id)
BQ061678 lymph, lymphoma, cell line .g 1 to 699 1 to 711   tiling clone,   709/1133
(62 %)
29 diff
(97.5 %id)
CA488491   .g 19 to 554 1 to 530       530/639
(82 %)
12 diff
(98.2 %id)
CX756086 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .g 59 to 785 1 to 714 P181H P182Q A184P M185C P186L ... tiling clone, Submitted on the opposite strand 714/749
(95 %)
13 diff
(98.3 %id)
BX417996 placenta .h 1 to 1100 1 to 1086 exact tiling clone, to resequence,   1086/1109
(97 %)
23 diff
(98.0 %id)
BX434450 placenta .h 1122 to 1688 583 to 19   tiling clone, to resequence,   565/872
(64 %)
51 diff
(94.2 %id)
AA335389 epididymis .h 1201 to 1536 1 to 336   tiling clone,   336/336
(100 %)
5 diff
(98.6 %id)
BX096095 liver and spleen .i 1 to 679 1 to 680   tiling clone,   680/680
(100 %)
2 diff
(99.8 %id)
R07842 liver and spleen .i 1 to 336 1 to 344       344/349
(98 %)
11 diff
(96.9 %id)
N59036 liver and spleen .i 82 to 381 1 to 300       300/307
(97 %)
1 diff
(99.7 %id)
AW084578 colon, colonic mucosa from 3 patients with Crohn'sdisease .i 470 to 1047 581 to 1   tiling clone,   581/581
(100 %)
4 diff
(99.4 %id)
N53948 liver and spleen .i 550 to 1039 492 to 1   tiling clone,   492/494
(99 %)
6 diff
(98.8 %id)
N55164 liver and spleen .i 600 to 1039 443 to 1   tiling clone,   443/444
(99 %)
3 diff
(99.4 %id)
CN286580 embryonic stem cells, cell lines H1, H7, andH9 .j -8 to 517 12 to 537 exact tiling clone,   526/537
(97 %)
5 diff
(99.1 %id)
TI_154188048   .k-u 1 to 863 128 to 982 P24A P28R K41R A48G Q57H ... tiling clone,   861/945
(91 %)
31 diff
(96.8 %id)
DA571047 whole embryo, mainly head .k-u 11 to 777 2 to 768   capped   767/767
(100 %)
4 diff
(99.5 %id)
CB993907 placenta, pre-eclamptic placenta .k-u 259 to 944 28 to 720 exact tiling clone,   693/940
(73 %)
17 diff
(98.2 %id)
CD709065 normal nasopharynx .k-u 278 to 918 35 to 673 R11W tiling clone,   639/673
(94 %)
7 diff
(99.0 %id)
BI012757 lung_tumor .k-u 824 to 1263 1 to 451   tiling clone,   451/451
(100 %)
34 diff
(92.5 %id)
AA226251   .k-u 1305 to 1646 1 to 343   tiling clone,   343/343
(100 %)
5 diff
(98.6 %id)
DB357866 whole embryo, mainly head .k-u 1313 to 1811 493 to 1   tiling clone,   493/495
(99 %)
18 diff
(96.4 %id)
BG222632 nasopharynx, normal epithelium .k-u 1404 to 1667 263 to 6       258/263
(98 %)
0 diff
(100 %id)
AA226616   .k-u 1492 to 1817 329 to 4   tiling clone,   326/329
(99 %)
0 diff
(100 %id)
BE152972 head_neck .k-u 1720 to 1875 154 to 1   tiling clone, Submitted on the opposite strand 154/154
(100 %)
3 diff
(98.1 %id)
AA512947 breast .l-u 1 to 487 483 to 1 exact tiling clone,   483/483
(100 %)
3 diff
(99.4 %id)
AW139570   .l-u 2 to 490 504 to 16 S12C tiling clone, AAA   489/489
(100 %)
1 diff
(99.8 %id)
R68350 placenta .l-u 23 to 276 1 to 259   fully sequenced,   259/259
(100 %)
4 diff
(98.5 %id)
R68560 placenta .l-u 246 to 490 245 to 1   fully sequenced,   245/245
(100 %)
5 diff
(98.0 %id)
BG394101 eye, retinoblastoma Gene SNRPA, variant not shown         Suspected internal deletion, this clone was ignored    
360 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k-u, .l-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI